Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
An Overview of Pediatric Pulmonary Complications During Covid-19 Pandemic: A Lesson for Future Publisher Pubmed



Roshanzamir Z1 ; Mohammadi F2 ; Yadegar A2 ; Naeini AM3 ; Hojabri K4 ; Shirzadi R2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Respiratory and Sleep Medicine Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. Pediatric Respiratory and Sleep Medicine Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran
  4. 4. Pediatric Intensive Care Unit, Shiraz University of Medical Sciences, Shiraz, Iran

Source: Immunity, Inflammation and Disease Published:2024


Abstract

Background: The pediatric community is considered a suitable target for controlling the spread and mortality of viral diseases. In late December 2019, a respiratory disease due to the novel coronavirus, later COVID-19, hit the globe. The COVID-19 global disruption had direct and indirect impacts on different aspects of child health. Therefore, surveillance, preventive approaches, and treatment plans for children came into the spotlight. Objective: This study aims to discuss the clinical pictures as well as laboratory and radiological findings of the infected children during the COVID-19 pandemic. The focus of this study is to express the clinical manifestations of respiratory disease in pediatric SARS-CoV-2, available therapeutic options, vaccine recommendations, and long COVID sequelae in affected children. This review could serve as a hint for upcoming challenges in pediatric care during future pandemics. Results: The clinical presentation of COVID-19 in pediatrics can range from mild pulmonary disease to acute respiratory distress syndrome (ARDS). Supportive care is a crucial component of the management of pediatric COVID-19. However, the importance of specializing in how to treat patients with more severe conditions cannot be overstated. Additionally, clinicians must consider prevention strategies as well as potential complications. Conclusion: Although the infected patients are dipping day by day, there is a lack of clinical guidelines for pediatric SARS-CoV-2-associated pulmonary diseases. Understanding of the physicians about all aspects of pediatric care during the COVID-19 pandemic could lead to enhanced quality of future patient care and safety, reduced costs of health policies, and surveil the risk that patients with respiratory viruses can expose to society. © 2024 The Author(s). Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.
Other Related Docs
13. Pediatric Endocrinopathies Related to Covid-19: An Update, World Journal of Pediatrics (2023)
25. A Review on Coronavirus Disease 2019 (Covid-19) in Pediatric Patients, Archives of Pediatric Infectious Diseases (2020)
32. Cardiovascular Manifestations in Covid-19 Patients: A Systematic Review and Meta-Analysis, Journal of Cardiovascular and Thoracic Research (2021)
38. Anticoagulant Therapy in Covid-19: A Narrative Review, Clinical and Translational Science (2023)
41. Dynamic Changes of Lymphocyte Subsets in the Course of Covid-19, International Archives of Allergy and Immunology (2021)
44. Case Fatality Rate of Covid-19: A Systematic Review and Meta-Analysis, Journal of Preventive Medicine and Hygiene (2021)
45. Ten Challenging Questions About Sars-Cov-2 and Covid-19, Expert Review of Respiratory Medicine (2020)
50. Being a Front-Line Dentist During the Covid-19 Pandemic: A Literature Review, Maxillofacial Plastic and Reconstructive Surgery (2020)